Skip to main content

Table 1 Baseline clinical examination results prior to study drug distribution (children 1–36 months at baseline)

From: The impact on malaria of biannual treatment with azithromycin in children age less than 5 years: a prospective study

Characteristic

Arm AZ, N = 360

Arm PL, N = 378

n

 

n

 

Age in months (mean (SD))

360

19.2 (11.0)

378

20.3 (11.0)

% Female

174

48.3

186

49.2

% Child has fever

28

7.8

23

6.1

% Child has had fever in the last 3 days

52

14.5

60

16.0

% Child is taken malaria medication

18

5.0

15

4.0

% Child is RDT positive

63

17.6

58

15.5

% Clinical malariaa

22

6.1

16

4.3

% Clinical malaria or taken malaria medication

33

9.2

25

6.7

  1. AZ azithromycin, PL placebo, RDT rapid diagnostic test for malaria, SD standard deviation
  2. aRDT positive plus current fever or reporting fever in the last 3 days